253 related articles for article (PubMed ID: 10841076)
1. Structure-function study of the extracellular domain of the human type I interferon receptor (IFNAR)-1 subunit.
Kumaran J; Colamonici OR; Fish EN
J Interferon Cytokine Res; 2000 May; 20(5):479-85. PubMed ID: 10841076
[TBL] [Abstract][Full Text] [Related]
2. Evidence for glycosphingolipid modification of the type 1 IFN receptor.
Ghislain J; Lingwood CA; Fish EN
J Immunol; 1994 Oct; 153(8):3655-63. PubMed ID: 7930586
[TBL] [Abstract][Full Text] [Related]
3. Identification of critical residues in bovine IFNAR-1 responsible for interferon binding.
Cutrone EC; Langer JA
J Biol Chem; 2001 May; 276(20):17140-8. PubMed ID: 11278538
[TBL] [Abstract][Full Text] [Related]
4. Mapping human interferon-alpha (IFN-alpha 2) binding determinants of the type I interferon receptor subunit IFNAR-1 with human/bovine IFNAR-1 chimeras.
Goldman LA; Cutrone EC; Dang A; Hao X; Lim JK; Langer JA
Biochemistry; 1998 Sep; 37(37):13003-10. PubMed ID: 9737881
[TBL] [Abstract][Full Text] [Related]
5. Homology model of human interferon-alpha 8 and its receptor complex.
Seto MH; Harkins RN; Adler M; Whitlow M; Church WB; Croze E
Protein Sci; 1995 Apr; 4(4):655-70. PubMed ID: 7613464
[TBL] [Abstract][Full Text] [Related]
6. Cloning and characterization of soluble and transmembrane isoforms of a novel component of the murine type I interferon receptor, IFNAR 2.
Owczarek CM; Hwang SY; Holland KA; Gulluyan LM; Tavaria M; Weaver B; Reich NC; Kola I; Hertzog PJ
J Biol Chem; 1997 Sep; 272(38):23865-70. PubMed ID: 9295335
[TBL] [Abstract][Full Text] [Related]
7. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
[TBL] [Abstract][Full Text] [Related]
8. Reconstitution of a high affinity binding site for type I interferons.
Russell-Harde D; Pu H; Betts M; Harkins RN; Perez HD; Croze E
J Biol Chem; 1995 Nov; 270(44):26033-6. PubMed ID: 7592797
[TBL] [Abstract][Full Text] [Related]
9. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
[TBL] [Abstract][Full Text] [Related]
10. A structural basis for interferon-alpha-receptor interactions.
Kumaran J; Wei L; Kotra LP; Fish EN
FASEB J; 2007 Oct; 21(12):3288-96. PubMed ID: 17517919
[TBL] [Abstract][Full Text] [Related]
11. The type I interferon receptor: structure, function, and evolution of a family business.
Mogensen KE; Lewerenz M; Reboul J; Lutfalla G; Uzé G
J Interferon Cytokine Res; 1999 Oct; 19(10):1069-98. PubMed ID: 10547147
[TBL] [Abstract][Full Text] [Related]
12. Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1.
Lamken P; Gavutis M; Peters I; Van der Heyden J; Uzé G; Piehler J
J Mol Biol; 2005 Jul; 350(3):476-88. PubMed ID: 15946680
[TBL] [Abstract][Full Text] [Related]
13. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta.
Abramovich C; Shulman LM; Ratovitski E; Harroch S; Tovey M; Eid P; Revel M
EMBO J; 1994 Dec; 13(24):5871-7. PubMed ID: 7813427
[TBL] [Abstract][Full Text] [Related]
14. Contributions of cloned type I interferon receptor subunits to differential ligand binding.
Cutrone EC; Langer JA
FEBS Lett; 1997 Mar; 404(2-3):197-202. PubMed ID: 9119063
[TBL] [Abstract][Full Text] [Related]
15. Structure-function study of the extracellular domain of the human IFN-alpha receptor (hIFNAR1) using blocking monoclonal antibodies: the role of domains 1 and 2.
Lu J; Chuntharapai A; Beck J; Bass S; Ow A; De Vos AM; Gibbs V; Kim KJ
J Immunol; 1998 Feb; 160(4):1782-8. PubMed ID: 9469437
[TBL] [Abstract][Full Text] [Related]
16. The human interferon receptor: NMR-based modeling, mapping of the IFN-alpha 2 binding site, and observed ligand-induced tightening.
Chill JH; Nivasch R; Levy R; Albeck S; Schreiber G; Anglister J
Biochemistry; 2002 Mar; 41(11):3575-85. PubMed ID: 11888273
[TBL] [Abstract][Full Text] [Related]
17. The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties.
Hardy MP; Owczarek CM; Trajanovska S; Liu X; Kola I; Hertzog PJ
Blood; 2001 Jan; 97(2):473-82. PubMed ID: 11154225
[TBL] [Abstract][Full Text] [Related]
18. Multiple regions within the promoter of the murine Ifnar-2 gene confer basal and inducible expression.
Hardy MP; Hertzog PJ; Owczarek CM
Biochem J; 2002 Jul; 365(Pt 2):355-67. PubMed ID: 11939908
[TBL] [Abstract][Full Text] [Related]
19. Domains of interaction between alpha interferon and its receptor components.
Uzé G; Di Marco S; Mouchel-Vielh E; Monneron D; Bandu MT; Horisberger MA; Dorques A; Lutfalla G; Mogensen KE
J Mol Biol; 1994 Oct; 243(2):245-57. PubMed ID: 7932753
[TBL] [Abstract][Full Text] [Related]
20. Activity of hybrid type I interferons in cells lacking Tyk2: a common region of IFN-alpha 8 induces a response, but IFN-alpha2/8 hybrids can behave like IFN-beta.
Platis D; Foster GR
J Interferon Cytokine Res; 2003 Nov; 23(11):655-66. PubMed ID: 14651780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]